TORONTO–(BUSINESS WIRE)–Halo Labs Inc. (“Halo” or the “Company“) (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that the Company has started a pilot superfiltration program of live resin, fats and waxes, tails, terpenes and low grade distillate at Halo’s Coastal Harvest facility in Cathedral City, California. Halo has specialized expertise in cannabis extraction…
DetailsCHICAGO–(BUSINESS WIRE)–Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or “the Company”), one of the largest vertically integrated multistate cannabis operators in the United States, today provided an update on the strategic initiative it has undertaken to increase the strength and depth of the Company’s senior leadership team. These key appointments position the Company to scale rapidly, efficiently,…
DetailsCHARLOTTE, N.C.–(BUSINESS WIRE)–cbdMD, Inc. (NYSE American: YCBD, YCBD PR A), a leading cannabidiol (CBD) consumer brand, announced today that in the coming weeks, cbdMD intends to offer third party manufactured single use alcohol-based hand sanitizers (which will not contain CBD) free with the purchase of cbdMD products, while supplies last. Details will be available on…
DetailsTORONTO–(BUSINESS WIRE)–Halo Labs Inc. (“Halo” or the “Company“) (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that the Company has started a pilot superfiltration program of live resin, fats and waxes, tails, terpenes and low grade distillate at Halo’s Coastal Harvest facility in Cathedral City, California. Halo has specialized expertise in cannabis extraction…
DetailsROSEVILLE, Minn.–(BUSINESS WIRE)–Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, has licensed a new method to help increase plant gene editing efficiency from the University of Minnesota. The method has the potential to reduce the time needed to edit plants from approximately one year to several months. This breakthrough, co-invented by Dan Voytas, Ph.D., the…
DetailsMONCTON, New Brunswick–(BUSINESS WIRE)–Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, today announced the temporary layoff of approximately 45 per cent of its workforce primarily to help boost COVID-19 containment efforts representing approximately 400 employees. “These are unprecedented and trying…
DetailsDUBLIN–(BUSINESS WIRE)–The “Regulatory Report: Thailand Seeks to Establish a Clear Legal Framework and Licensing Regime” report has been added to ResearchAndMarkets.com’s offering. This report provides an invaluable overview of the complex regulatory framework relating to CBD in Thailand. The regulations within this country are restrictive, made worse by the absence of a fully established licensing…
DetailsTORONTO–(BUSINESS WIRE)–Halo Labs Inc. (“Halo” or the “Company”) (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce it has entered into a definitive agreement (the “Agreement”) all of the common shares of Nasalbinoid Natural Devices Corp. (“Nasalbinoid” or “NND”) for C$5.1 million in Halo common shares at a deemed price of C$0.15 per share…
DetailsCHICAGO–(BUSINESS WIRE)–Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or “the Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it received an adult-use dispensing organization license from the Illinois Department of Financial Regulation for its dispensary located at 436 N. Clark Street in the prestigious River North neighborhood of…
DetailsCHARLOTTE, N.C.–(BUSINESS WIRE)–cbdMD, Inc. (NYSE American: YCBD, YCBD PR A), a leading cannabidiol (CBD) consumer brand, announced today that its preliminary year over year sales for the second quarter of fiscal 2020 ended March 31, 2020 grew 167% to approximately $9.4 million from its second quarter fiscal 2019 quarterly sales of $5.64 million. “We are…
DetailsTORONTO–(BUSINESS WIRE)–Halo Labs Inc. (“Halo” or the “Company”) (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce it has entered into a definitive agreement (the “Agreement”) all of the common shares of Nasalbinoid Natural Devices Corp. (“Nasalbinoid” or “NND”) for C$5.1 million in Halo common shares at a deemed price of C$0.15 per share…
DetailsBOSTON–(BUSINESS WIRE)–Pear Therapeutics, Inc. presented results today from an open-label study that evaluated participant engagement and satisfaction with reSET® and reSET-O®, prescription digital therapeutics (PDTs) that deliver evidence-based disease treatment through cognitive behavioral therapy, fluency training and contingency management for substance use disorder (SUD) and opioid use disorder (OUD) via mobile device. Study participants showed…
Details